ORCID as entered in ROS

Select Publications
2025, 'Which chemotherapy treatments are best for helping people with advanced pancreatic cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)', Journal of Modern Oncology, 27, pp. 58 - 59, http://dx.doi.org/10.26442/18151434.2025.1.203224
,2024, 'Chemotherapy and radiotherapy for advanced pancreatic cancer', Cochrane Database of Systematic Reviews, 2024, http://dx.doi.org/10.1002/14651858.CD011044.pub3
,2024, 'Application of a revised model for coping with advanced cancer to qualitatively explore lung cancer survivors’ experiences of ongoing physical effects, novel treatments, uncertainty, and coping', Journal of Cancer Survivorship, 18, pp. 1754 - 1770, http://dx.doi.org/10.1007/s11764-023-01417-x
,2024, 'Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study', Journal of Robotic Surgery, 18, http://dx.doi.org/10.1007/s11701-024-01910-0
,2024, 'STEM-01. SHARED ASTROCYTE-LIKE GLIOMA STEM CELLS DRIVE HETEROGENEITY AND IMMUNE DYNAMICS IN ADULT-TYPE DIFFUSE GLIOMAS', Neuro-Oncology, 26, pp. viii57 - viii57, http://dx.doi.org/10.1093/neuonc/noae165.0227
,2024, 'A BRAIN CANCER CELL ATLAS REVEALS SHARED ASTROCYTE-LIKE STEM CELL STATES DRIVE INTRATUMOURAL HETEROGENEITY AND SHAPE IMMUNE DYNAMICS IN ADULT-TYPE DIFFUSE GLIOMAS', NEURO-ONCOLOGY, 26, pp. V3 - V3, http://dx.doi.org/10.1093/neuonc/noae144.007
,2024, 'Impact of COVID-19 on lung cancer care in New South Wales, Australia: real-world data from the EnRICH Program', Public Health Research and Practice, 34, http://dx.doi.org/10.17061/phrp3432423
,2024, 'ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance', Jto Clinical and Research Reports, 5, http://dx.doi.org/10.1016/j.jtocrr.2024.100703
,2024, 'Onkolytische Viren zur Verstärkung der PD-1-Hemmung bei metastasierendem kutanem Plattenepithelkarzinom', JDDG Journal of the German Society of Dermatology, 22, pp. 1016 - 1019, http://dx.doi.org/10.1111/ddg.15423_g
,2024, 'Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma—RIOMeso', Journal of Thoracic Oncology, 19, pp. 636 - 642, http://dx.doi.org/10.1016/j.jtho.2023.11.014
,2024, 'Development of clinically meaningful quality indicators for contemporary lung cancer care, and piloting and evaluation in a retrospective cohort; experiences of the Embedding Research (and Evidence) in Cancer Healthcare (EnRICH) Program', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-074399
,2024, 'Carrying on with life as a lung cancer survivor: a qualitative study of Australian survivors’ employment, finances, relationships, and healthcare experiences', Translational Lung Cancer Research, 13, pp. 785 - 798, http://dx.doi.org/10.21037/tlcr-23-815
,2024, 'Oncolytic viruses to augment PD-1 inhibition in metastatic cutaneous squamous cell carcinoma', JDDG - Journal of the German Society of Dermatology, 22, pp. 1016 - 1018, http://dx.doi.org/10.1111/ddg.15423
,2023, 'Transitioning single-cell genomics into the clinic', Nature Reviews Genetics, 24, pp. 573 - 584, http://dx.doi.org/10.1038/s41576-023-00613-w
,2023, 'A phase 2 study of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma: ELEVATE HNSCC.', Journal of Clinical Oncology, 41, pp. TPS6102 - TPS6102, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.tps6102
,2023, 'A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma', Cancer Medicine, 12, pp. 11234 - 11247, http://dx.doi.org/10.1002/cam4.5815
,2023, 'Air pollution and lung cancer—A new era', Respirology, 28, pp. 313 - 315, http://dx.doi.org/10.1111/resp.14464
,2023, 'Two Very Rare Cases of Metastatic Thymic Carcinoma with Sjogren's Syndrome: A Case Series', Case Reports in Oncology, 16, pp. 122 - 129, http://dx.doi.org/10.1159/000529425
,2023, 'Immune checkpoint inhibitors for advanced pancreatic cancer', Cochrane Database of Systematic Reviews, 2023, http://dx.doi.org/10.1002/14651858.CD014523
,2023, 'Clinicians' Evaluation of Lung Cancer Clinical Quality Indicators and Comparative Performance Data in Practice', European Journal of Cancer Care, 2023, http://dx.doi.org/10.1155/2023/6636704
,2023, 'MA17.05 Real World Outcomes of Immunotherapy (IO) for Pleural MESOthelioma in Australia - RIOMeso', Journal of Thoracic Oncology, 18, pp. S163 - S163, http://dx.doi.org/10.1016/j.jtho.2023.09.239
,2023, 'P2.10-01 ALKTERNATE: A Pilot Study Alternating Lorlatinib with Crizotinib in Patients with ALK+ NSCLC and ALK-inhibitor Resistance', Journal of Thoracic Oncology, 18, pp. S351 - S352, http://dx.doi.org/10.1016/j.jtho.2023.09.616
,2022, 'High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer', Journal of Pathology Clinical Research, 8, pp. 355 - 370, http://dx.doi.org/10.1002/cjp2.269
,2022, 'Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review', Immunotherapy, 14, pp. 511 - 520, http://dx.doi.org/10.2217/imt-2021-0225
,2022, 'Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer', Cancer Treatment and Research Communications, 32, http://dx.doi.org/10.1016/j.ctarc.2022.100576
,2022, 'EP10.01-005 Australian Lung Cancer Survivors Experiences of Novel Treatments, Healthcare, and Ongoing Physical and Psychological Needs', Journal of Thoracic Oncology, 17, pp. S502 - S502, http://dx.doi.org/10.1016/j.jtho.2022.07.882
,2022, 'EP16.03-041 Single Cell RNA Sequencing Reveals Phenotypic Predispositions to Developing Lung Cancer in Never-Smokers', Journal of Thoracic Oncology, 17, pp. S608 - S608, http://dx.doi.org/10.1016/j.jtho.2022.07.1102
,2021, 'A single-cell tumor immune atlas for precision oncology', Genome Research, 31, pp. 1913 - 1926, http://dx.doi.org/10.1101/gr.273300.120
,2021, 'Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancer', Cochrane Database of Systematic Reviews, 2021, http://dx.doi.org/10.1002/14651858.CD010584.pub2
,2021, 'Altered presentation of oropharyngeal cancer, a 6-year review', ANZ Journal of Surgery, 91, pp. 1240 - 1245, http://dx.doi.org/10.1111/ans.16537
,2021, 'A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma', Elife, 10, http://dx.doi.org/10.7554/eLife.65234
,2021, 'Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer', Gastroenterology, 160, pp. 362 - 377.e13, http://dx.doi.org/10.1053/j.gastro.2020.09.043
,2021, 'P24.03 Dynamic Circulating Tumor DNA Interim Results From The ALKternate Clinical Trial', Journal of Thoracic Oncology, 16, pp. S1030 - S1032, http://dx.doi.org/10.1016/j.jtho.2021.08.368
,2021, 'P37.19 Activin-A and GDF-11 as Predictive Biomarkers for Platinum Response in Non-Small Cell Lung Cancer', Journal of Thoracic Oncology, 16, pp. S450 - S450, http://dx.doi.org/10.1016/j.jtho.2021.01.766
,2021, 'P60.01 Single-Cell Transcriptomics to Assess Response to Immunotherapy in Advanced Lung Cancer ex-vivo: Developing a Functional Predictive Assay', Journal of Thoracic Oncology, 16, pp. S540 - S541, http://dx.doi.org/10.1016/j.jtho.2021.01.960
,2020, 'Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer', Annals of Surgery, 272, pp. 366 - 376, http://dx.doi.org/10.1097/SLA.0000000000003143
,2020, 'Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma', Elife, 9, pp. 1 - 25, http://dx.doi.org/10.7554/eLife.53367
,2020, 'Activin as a biomarker for platinum resistance in non-small cell lung cancer.', Journal of Clinical Oncology, 38, pp. e21737 - e21737, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e21737
,2020, 'HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer', Cell Reports, 31, http://dx.doi.org/10.1016/j.celrep.2020.107625
,2020, 'The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies', Cancer Immunology Immunotherapy, 69, pp. 343 - 354, http://dx.doi.org/10.1007/s00262-019-02453-2
,2020, 'Nutritional parameters associated with hospital admissions in patients being treated for head and neck cancer', Supportive Care in Cancer, 28, pp. 341 - 349, http://dx.doi.org/10.1007/s00520-019-04826-w
,2020, 'A Non-Genetic, Cell Cycle Dependent Mechanism of Platinum Resistance in Lung Adenocarcinoma', , http://dx.doi.org/10.1101/2020.11.26.400499
,2019, 'Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer', Oncogene, 38, pp. 1661 - 1675, http://dx.doi.org/10.1038/s41388-018-0536-1
,2019, 'Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism', Endocrinology Diabetes and Metabolism Case Reports, 2019, http://dx.doi.org/10.1530/EDM-19-0098
,2019, 'Cyclin E1 is a shared biomarker of subsets of high grade serous ovarian cancer (HGSOC) and basal like breast cancer (BLBC)', Annals of Oncology, 30, pp. ix86 - ix86, http://dx.doi.org/10.1093/annonc/mdz426.029
,2018, 'Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer', Gut, 67, pp. 2142 - 2155, http://dx.doi.org/10.1136/gutjnl-2017-315144
,2018, 'Prospective Evaluation of the Clinical Utility of the International Lung Screen Trial Lung Nodule Management Protocol', JOURNAL OF THORACIC ONCOLOGY, 13, pp. S362 - S363, http://dx.doi.org/10.1016/j.jtho.2018.08.332
,2018, 'MASTL overexpression promotes chromosome instability and metastasis in breast cancer', Oncogene, 37, pp. 4518 - 4533, http://dx.doi.org/10.1038/s41388-018-0295-z
,2018, 'Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy', Science Translational Medicine, 10, http://dx.doi.org/10.1126/scitranslmed.aat3504
,2018, 'Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future', Internal Medicine Journal, 48, pp. 637 - 644, http://dx.doi.org/10.1111/imj.13810
,